Simulations Plus develops modeling and simulation software and provides consulting services for the pharmaceutical and biotechnology industries. The company's technical focus spans artificial intelligence, machine learning, physiologically based pharmacokinetics (PBPK), quantitative systems pharmacology (QSP), and pharmacometric modeling. Its product portfolio includes GastroPlus for PBPK modeling, ADMET Predictor for property prediction, MonolixSuite for PK/PD modeling, DILIsym for liver toxicity assessment, and Thales for crystallization simulation.
The company maintains offices in Lancaster, California, and Research Triangle Park, North Carolina. It is publicly traded on NASDAQ under the ticker symbol SLP.
